Mask Up, Cosibelimab, Arterial ThrombosisSeptember 28, 2020 | Oncology Allergy & Immunology If You Don’t Want to Wear a Mask, Come to Work with Me In this KevinMD podcast/article, Dr. Gregory Jasani, an emergency medicine physician in an inner-city, discusses his experiences treating COVID-19 patients and his thoughts surrounding the current mask mandates across the country. In his experience, wearing a mask is not about a person’s civil liberties, but rather the numbers game when you work in healthcare. Read full article Dermatology Cosibelimab Safe, Clinically Active in Patients With mCSCC In Study CK-301-101, the primary efficacy endpoint was objective response rate (complete + partial response, by independent central review), which was 47% (n = 15) in 32 metastatic cutaneous squamous cell carcinoma (mCSCC) patients evaluable for response, including three complete responses and 12 partial responses. The results from the study were presented at the ESMO Congress. Read full article Cardiology How I Treat Unexplained Arterial Thrombosis In this “How I Treat” feature from Blood, the authors conclude with three representative cases to both illustrate the application of the outlined diagnostic schema and discuss common management considerations, specifically the selection of anticoagulation vs. antiplatelet therapy for secondary prevention. Read full article
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH